Sanofi CEO promises clearer picture
Article Abstract:
The new Chief Executive Officer, Gerard Le Fur of Sanofi-Aventis S.A. of France is talking up its drug line. The pharmaceutical house is beginning to reveal the potential of its experimental drugs in a bid to create more investor interest and increase its stock price.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Betting $10 billion on generics, Novartis seeks to inject growth
Article Abstract:
Chief Executive Officer Daniel Vasella, Novartis AG of Switzerland is promoting both its generic and brand name operations. The generics market is forecast to be worth $100 billion by 2010 and Novartis AG expects to have 10 percent market share.
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: SkyePharma attracts interest. AstraZeneca is on prowl outside its own lab walls. Big drug makers take a pass on Serono
- Abstracts: Swisscom gets approval for foreign takeovers. Alder steps down from Swisscom after Eircom row. Swisscom eases plans to invest in foreign firms
- Abstracts: Bring on the ads. The fickle beer consumer. Make way for the 'ad pod'
- Abstracts: FDA panel votes to return MS drug Tysabri to market. Sanofi withdraws obesity-drug application in U.S. 'Miracle' obesity pill looks less miraculous: repeated FDA delays, European restrictions ail Sanofi's Acomplia